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ABSTRACT
Diet-induced obesity is associated with increased adipose tissue activated 
macrophages. Yet, how macrophages integrate fatty acid (FA) signals remains 
unclear. We previously demonstrated that Fyn deficiency (fynKO) protects against 
high fat diet-induced adipose tissue macrophage accumulation. Herein, we show that 
inflammatory markers and reactive oxygen species are not induced in fynKO bone 
marrow-derived macrophages exposed to the saturated FA palmitate, suggesting that 
Fyn regulates macrophage function in response to FA signals. Palmitate activates Fyn 
and re-localizes Fyn into the nucleus of RAW264.7, J774 and wild-type bone marrow-
derived macrophages. Similarly, Fyn activity is increased in cells of adipose tissue 
stromal vascular fraction of high fat-fed control mice, with Fyn protein being located 
in the nucleus of these cells. We demonstrate that Fyn modulates palmitate-dependent 
oxidative stress in macrophages. Moreover, Fyn catalytic activity is necessary for its 
nuclear re-localization and downstream effects, as Fyn pharmacological inhibition 
abolishes palmitate-induced Fyn nuclear redistribution and palmitate-dependent 
increase of oxidative stress markers. Importantly, mono-or polyunsaturated FAs 
do not activate Fyn, and fail to re-localize Fyn to the nucleus. Together these data 
demonstrate that macrophages integrate nutritional FA signals via a differential 
activation of Fyn that distinguishes, at least partly, the effects of saturated versus 
unsaturated fats.
INTRODUCTION
Obesity, the most potent trigger for the development 
of type 2 diabetes and insulin resistance, has reached 
pandemic proportions and will affect more than 475 
million individuals worldwide in the next 15 years [1]. 
Obesity is the result of dysregulation of a number of 
biological processes, including the disturbance of whole 
body homeostasis including immune functions [2]. In 
this regard, obesity is associated with systemic low-grade 
inflammation, also called meta-inflammation characterized 
by accumulation of immune cells in peripheral tissues 
such as liver, skeletal muscle and adipose tissue [3–6]. In 
addition to the increased immune cell number, obesity-
induced inflammation is defined by a modification of 
immune cell populations with increased B [6] and T 
lymphocytes [7], neutrophils [8] and mast cells [9]; and 
decreased natural killer cells and eosinophil numbers, 
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promoting insulin resistance, particularly in the adipose 
tissues of obese individuals [10]. Interestingly, meta-
inflammation shares similar sets of signaling pathways 
with classical inflammation. However, the hallmark of 
meta-inflammation is that the inflammatory processes are 
stimulated by the same excessive nutrient supply that also 
dysregulates energy metabolism and insulin sensitivity.
Remarkably, macrophages can represent up to 
40% of the adipose tissue cell population in morbidly 
obese patients [11]; and there is substantial evidence 
that macrophages are involved in the establishment of 
inflammation-associated insulin resistance in this tissue. 
However, it is still under scrutiny whether the sole 
increase in macrophage number [12] or a switch in their 
phenotype from anti- to pro-inflammatory [13, 14] is 
responsible for this inflammation. Recently, the presence 
of macrophages distinct from the M1 pro-inflammatory 
phenotype and resemble the M2 phenotype have been 
described in adipose tissues of obese humans and mice 
[14]. Interestingly, these macrophages display a unique set 
of markers involved in lipid metabolism and induced by 
the saturated fatty acid (FA) palmitate, demonstrating that 
high fat diets induce a change in macrophage phenotype 
and function.
Determining the molecular mechanisms that trigger 
these changes under a high fat diet regime is likely to 
offer insights into the metabolic consequences of obesity. 
However, how cells “sense” FA cues remains to be 
clarified. In this regard, recent studies have focused on 
molecules that could provide a link between FA sensing 
and immune function. AMP-activated protein kinase 
(AMPK) has recently being suggested to mediate some 
of the anti-inflammatory effects of unsaturated FAs in 
macrophages [15, 16] by decreasing pro-inflammatory 
gene expression [17, 18]. Recently, the nuclear-factor 
erythroid 2-related factor 2 (Nrf2), a transcription factor 
playing physiological roles in oxidative stress has emerged 
as an important factor in the orchestration of the effects of 
FAs on macrophage function [19]. Indeed, high fat feeding 
inhibits Nrf2 downstream targets [20]. Interestingly, Fyn 
tyrosine kinase phosphorylates Nrf2, promoting Nrf2 
nuclear exclusion and subsequent degradation [21–23].
Fyn-a member of the Src family of non-receptor 
tyrosine kinases- is an important molecule in the 
integration of metabolic and inflammatory pathways. Its 
role as a modulator of the innate immune function is well 
established, and we have previously demonstrated that Fyn 
is a key regulator of glucose and energy homeostasis [24]. 
Consistently with the role of Fyn in lipid metabolism, 
we have demonstrated that fyn-deficient (fynKO) mice 
display higher rates of long chain FA oxidation, as a result 
of enhanced LKB1 and AMPK activities in adipose tissue 
and skeletal muscle [25]. More recently, we reported that 
Fyn deficiency protects animals from diet-induced insulin 
resistance despite induction of obesity [26]. Importantly, 
we showed that the number of macrophages was greatly 
reduced in the adipose tissue of fynKO animals after a 
high fat diet [26]. This suggested that Fyn might regulate 
macrophage function in response to FAs. Therefore, in 
this report we investigated 1) the role of Fyn kinase in 
saturated FA-induced macrophage activation and 2) the 
effects of saturated and unsaturated FAs on Fyn function 
and downstream signaling.
RESULTS
Increased Fyn activity in adipose tissue stromal 
vascular fraction of high fat-fed mice
High fat diet-fed fynKO mice display reduced 
systemic inflammation and decreased macrophage 
Figure 1: Fyn kinase expression and activity are increased in isolated ATMs and SVF of high fat-fed mice. (A) Fyn 
protein expression in adipose tissue macrophages (ATMs) from low fat-fed (10% Kcal) and high fat-fed (60% Kcal) mice (n=8). P115 was 
used as loading control. (B) Signal quantification of Fyn protein expression normalized by p115. (C) Fyn tyrosine kinase activity in the 
stromal vascular fraction of adipose tissue of mice fed either a 10% Kcal fat diet or a 60% Kcal fat diet for 8 weeks, (n=4 experiments), *p 
(60% vs. 10%) <0.05.
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number in the stromal vascular fraction (SVF) of their 
adipose tissue [26], suggesting that Fyn participates in 
the deleterious effects of high fat diets on inflammatory 
processes. Interestingly, Fyn protein expression was 
significantly increased in isolated adipose tissue 
macrophages (ATMs) from wild type mice following 
8 weeks of high fat diet (60% Kcal) (Figure 1A, B). 
Consistent with this increase, Fyn tyrosine kinase activity 
was increased more than 2-fold in the SVF of adipose 
tissue of high fat-fed mice (Figure 1C), suggesting that 
dietary fats might regulate Fyn activity.
Inflammation markers and ROS are reduced in 
palmitate-treated fynKO macrophages
To investigate the mechanisms by which Fyn 
expression/activity affects macrophage response to 
FAs, we first assessed inflammatory marker expressions 
in isolated ATMs from high fat-fed control and fynKO 
mice. Consistent with our previous report [26], TNFα 
and IL6 expression were reduced in macrophages from 
high fat-fed fynKO mice (Figure 2A). Importantly, 
whilst palmitate increased inflammatory markers (NOS2, 
Figure 2: Inflammation markers and ROS production are reduced in Fyn-deficient macrophages. (A) Inflammation 
markers (IL6, TNFα) in wild type (WT) and fynKO mice ATMs. (B) Inflammation markers (NOS2, IL6, TNFα) in bone marrow-derived 
macrophages (BMDMs) of WT and fynKO mice treated with 150 μM palmitate (PA) (dark bars) or BSA alone (Mock) (open bars) 
(PA:BSA=2) (n=3 experiments). * p<0.05. (C) RAW264.7 macrophages were infected with either shRNA encoding for a non-mammalian 
target (non-target) or fyn sequences (shFyn). Fyn protein expression was determined by immunoblotting in two separate cell lines. (D) ROS 
production in shFyn-RAW264.7 cells and control cells (non-target) treated with 150 μM PA or with BSA alone (Mock) (PA:BSA=2). Data 
were normalized to mock in control cells (n= 4 experiments), * non-target mock vs. non-target PA p<0.05; **shFyn mock vs. shFyn PA 
p<0.05; & non-target PA vs. shFyn PA p<0.05. (E) NAD(P)H oxidase mRNA expression in BMDMs of WT and fynKO mice treated with 
150 μM PA (dark bars) or with BSA alone (open bars) for 4 h (PA:BSA=2), (n=4 experiments), * WT mock vs. WT PA p<0.05; ** fynKO 
mock vs. fynKO PA p<0.05, & WT PA vs. fynKO PA p<0.05.
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IL6 and TNFα) in bone marrow-derived macrophages 
(BMDMs) from low fat-fed control mice, these markers 
were not induced in BMDMs of low fat-fed fynKO 
mice (Figure 2B). Using shRNA-mediated knock down, 
we silenced fyn in RAW264.7 macrophages (shFyn-
RAW264.7) (Figure 2C). The reactive oxygen species 
(ROS) production that accompanies the early stage of 
inflammatory processes was increased in RAW264.7 
macrophages after incubation with palmitate, but not in 
shFyn-RAW264.7 macrophages (Figure 2D). Similarly, 
NAD(P)H oxidase expression, the enzyme catalyzing 
the production of superoxide, was not induced in 
fyn-deficient macrophages after palmitate exposure 
(Figure 2E). These data suggest that lack of Fyn kinase 
expression in macrophages is required to lessen the 
inflammatory effects mediated by saturated FAs.
Saturated but not unsaturated FAs redistribute 
Fyn in the nucleus of macrophages
Fyn subcellular localization varies from 
cytoplasmic to nuclear depending on which signals 
the cells were exposed to [22, 27]. Interestingly, Fyn 
protein expression was increased in the adipose tissue 
Figure 3: Palmitate exposure induces Fyn nuclear re-localization. (A) Cellular fractionation of cells from adipose tissue stromal 
vascular fractions from low fat-fed (CD) and high fat-fed (HFD) control mice. Fyn protein expression was assessed in cytoplasmic and 
nuclear fractions. (B) RAW264.7 macrophages (a-d), BMDMs from wild type mice (e-h) and J774 macrophages (i-l) were incubated with 
BSA (Mock) or 150 μM palmitate (PA) (FA:BSA=2). Nuclei (a, c; e, g; i, k) were visualized using DAPI staining and Fyn subcellular 
localization (b, d; f, h; j, l) was assessed by immunofluorescence (n=7 experiments). (C) Fyn subcellular localization in RAW264.7 
macrophages incubated with BSA (Mock) or 150 μM Oleate or 150 μM DHA (FA:BSA=2) for 10 min (n=4 experiments). (D) Fyn subcellular 
localization in RAW264.7 macrophages incubated with a mixture of palmitate (PA) and DHA at different ratios, (n=3 experiments).
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SVF of high fat-fed mice (Figure 3A), consistent with 
increased Fyn activity (Figure 1C). Also, Fyn protein 
expression was increased in the nuclear fraction of SVF 
from high fat-fed mice whilst Fyn signal was higher 
in the cytoplasm fraction of SVF from low fat-fed 
mice (Figure 3A). Together, these data suggested that 
high fat-diet re-localized Fyn into the nucleus of cells. 
Consistent with this, endogenous Fyn was predominantly 
localized in the cytoplasm of mock (BSA)-stimulated 
RAW264.7 cells but was re-distributed to the nucleus 
following palmitate exposure (Figure 3B, panels a-d). 
Similar results were obtained with wild type BMDMs 
(Figure 3B, panels e-h) and the J774 macrophage cell 
line (Figure 3B, panels i-l). The percentage of cells with 
Fyn signal predominantly in the nucleus in each cell line 
is presented in Supplementary Figure 1A, B and C.
Interestingly, Fyn re-distribution to the nucleus 
appeared to be restricted to palmitate treatment, as Fyn 
remained in the cytoplasm in 70% of cells treated with the 
mono-unsaturated FA oleate and in approximately 85% of 
cells exposed to the polyunsaturated FA docosahexaenoic 
acid (DHA) (Figure 3C and Supplementary Figure 2A) 
or polyunsaturated FA eicosapentaenoic acid (data not 
shown). In line with this, subcellular fractionation of 
RAW264.7 cells confirmed that Fyn localized in nuclear 
fractions after palmitate exposure but localized in the 
cytoplasm after incubation with DHA (Supplementary 
Figure 2B). Fyn also localized to the nucleus in 80% of 
the cells exposed to a mixture of saturated (palmitate) and 
unsaturated (DHA) FAs at a ratio similar to that found in 
high fat diets (PA:DHA ratio = 2) (Figure 3D). But, only 
20% of the cells presented Fyn in the nucleus (Figure 
3D) when they were incubated in a mixture where DHA 
concentration was higher than this of palmitate (PA:DHA 
ratio = 0.5). These results are essentially consistent with 
the fact that Fyn protein can be found in the nucleus of 
Figure 4: Fyn activity is necessary for palmitate-dependent Fyn nuclear re-localization. (A) RAW264.7 macrophages were 
incubated with BSA (a, b); 5 µM SU6656 (c, d), 150 µM palmitate (PA) (e, f) or SU6656 and palmitate (g, h) (PA:BSA=2). Nuclei and 
Fyn localization were visualized as above, (n=5 experiments). (B) Percentage of RAW264.7 cells with Fyn signal detected in the nucleus 
(n=5 experiments),* p (PA vs. BSA) <0.05. (C) RAW264.7 macrophages were incubated with BSA or 150 µM Oleate or 150 µM DHA 
(FA:BSA=2) for 10 min. Fyn kinase activity was assessed as described in Material and Methods (n=4 experiments), *p (FA vs. BSA)<0.05.
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Figure 5: Fyn regulates Nrf2 subcellular localization and its downstream targets in response to palmitate. (A) RAW264.7 
macrophages were incubated with BSA or 150 μM PA for the indicated times (PA:BSA=2). Nuclei were visualized using DAPI staining, 
Fyn and Nrf2 subcellular localizations were assessed by immunofluorescence (n=4 experiments). (B) Cellular fractionation of RAW264.7 
macrophages incubated with BSA, 150 μM PA for 10 minutes or 60 min was performed (PA:BSA=2). Fyn and Nrf2 protein expressions 
were assessed in cytoplasmic and nuclear fractions. (C) Nqo-1 mRNA expression in RAW264.7 macrophages incubated with BSA, 150 μM 
PA or 5 μM SU6656 and 150 μM PA (SU/PA), * p<0.05 (n=4). (D) HO-1 protein expression in RAW264.7 macrophages in response to 150 
μM PA or 5 μM SU6656 and 150 μM PA (SU/PA) (n=3 experiments). (E) Signal quantification of HO-1 protein expression in RAW264.7 
cells corrected by actin and normalized to BSA condition. * p<0.05 (n=3).
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SVF from low-fat fed mice (Figure 3A), as the mice are 
also exposed, although in lesser amount, to saturated fats 
in their diet.
Saturated but not unsaturated FAs activate Fyn 
kinase in macrophages
Palmitate-induced Fyn nuclear re-localization was 
blocked when cells were treated with the Fyn kinase 
inhibitor SU6656 (Figure 4A, panels g, h and Figure 
4B), suggesting that Fyn kinase catalytic activity was 
required for palmitate-mediated Fyn nuclear localization. 
Supporting this, Fyn kinase activity was 6-fold higher 
in cells treated with palmitate, whilst it was much more 
moderately increased, if at all, after oleate (2-fold) or DHA 
(no increase) exposure (Figure 4C).
Fyn inhibition blocks palmitate pro-
inflammatory effects
To investigate the physiological relevance of Fyn 
subcellular re-localization after palmitate exposure, and 
whether this affects macrophage activation in response 
to saturated fats, we next investigated palmitate effects 
on Nrf2 subcellular localization. Nrf2 is an important 
transcription factor that regulates anti-oxidative gene 
expression and is under Fyn regulatory control. Nrf2 
localized in the cytoplasm of un-stimulated RAW264.7 
macrophages (Figure 5A) as previously reported [28–30]. 
Time course experiments in RAW264.7 macrophages 
treated with palmitate revealed that both Fyn and Nrf2 
accumulated in the nucleus after a short palmitate 
exposure (Figure 5A). However, while Fyn remained in 
the nucleus (Figure 5A, middle panels), the Nrf2 signal 
decreased in the nucleus with time (Figure 5A, right 
panels) and Nrf2 was cytosolic in approximately 75 % 
of cells after 10 minutes (Figure 5A and Supplementary 
Figure 3). This was essentially confirmed by subcellular 
fractionations of RAW264.7 cells (Figure 5B). Notably, 
Nrf2 expression appeared slightly reduced after 10 min 
and is decreased after 60 min (Figure 5B, lower panel), 
which could be explained by increased Keap1 expression 
and correlated increase in Nrf2 ubiquitination levels 
detected at 10 min and robustly observed after 30 min 
(Supplementary Figure 4). To evaluate Nrf2 functionality 
after palmitate exposure, Nrf2 downstream targets 
NAD(P)H dehydrogenase [quinone]-1 (Nqo-1) and Heme 
oxygenase-1 (HO-1) mRNA and protein expression were 
determined in RAW264.7 cells. Consistently with Nrf2 
cytosolic localization, Nqo-1 mRNA expression was 
reduced after palmitate treatment. Importantly, Nqo-1 
expression was rescued after Fyn inhibition with SU6656 
(Figure 5C). Similarly, HO-1 protein expression was 
reduced after palmitate treatment and rescued after Fyn 
inhibition with SU6656 in RAW264.7 (Figure 5D, E) as 
well as in J774 (Supplementary Figure 5) macrophage 
models.
DISCUSSION
Obesity is a major worldwide health dilemma 
aggravated by refined diets rich in fats. Obesity is 
characterized by chronic low-grade inflammation 
and high fat diets promote invasion of immune cells, 
particularly macrophages into peripheral tissues. Recent 
studies have suggested that the number of macrophages 
[12] rather than their phenotype increases inflammation 
in obese individuals. This is also supported by the recent 
observation that M1 cell-surface markers are lacking in 
ATMs of obese humans and mice [14], which demonstrates 
that the phenotypic switch from anti-inflammatory (M2) 
to pro-inflammatory (M1) macrophages, and its role 
in adipose tissue inflammation is more complex than 
originally described. However, Kratz et al. [14] also 
showed that the saturated FA palmitate stimulates the 
macrophage population to resemble the M1 phenotype, 
e.g. by having an increased lipogenic profile. This strongly 
supports the concept that high-fat diets participate in the 
modification of the macrophage activation in peripheral 
tissues. However, not all fats are equal. Indeed, saturated 
fatty acids (FAs) increase pro-inflammatory gene 
expression, cytokine expression and reactive oxygen 
species (ROS) production in macrophages [31, 32] whilst 
unsaturated, particularly n-3 polyunsaturated FAs (PUFAs) 
reduce pro-inflammatory processes in macrophages [33]. 
Whilst the effects of FAs on metabolic cascades (e.g. 
insulin signaling) have been largely studied, the role of 
these nutrients and how they modulate immune function 
is still unclear. Particularly, the molecular links (or 
“sensors”) relaying FA effects on the macrophage function 
are still unknown. Therefore, molecules linking immune 
function and energy are of special interest. Previously, 
we showed that Fyn is a regulator of whole body lipid 
metabolism [24]. Remarkably, Fyn is also a major 
regulator of innate immune function, participating in Toll-
Like Receptor (TLR) signaling in macrophages as well as 
in T-cell receptor signaling in T cells [34]. Additionally, 
Fyn interacts with the FA transporter CD36 [35, 36], 
which expression is greatly induced in palmitate-treated 
macrophages [14]. Therefore, we hypothesized that Fyn 
may transduce the inflammatory effects of saturated FAs. 
Consistently, we determined that Fyn kinase activity was 
greatly increased in response to palmitate; and palmitate 
pro-inflammatory effects were blunted in BMDMs lacking 
Fyn. Interestingly, PUFAs such as DHA were unable 
to activate Fyn; and Fyn was not re-localized to the 
nucleus in response to DHA (Figure 3 and Figure 4). This 
suggested that Fyn activation might be part of a signaling 
cascade distinguishing between the effects of saturated and 
unsaturated FAs on macrophage function. Further studies 
are necessary to identify mechanisms by which saturated 
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and unsaturated FAs have divergent effects of Fyn kinase 
activation. It is suggested that Fyn distributes diffusely 
throughout the plasma membrane in some macrophage 
models and under particular stimuli, Fyn may undergo 
endocytosis [37]. As such, one could argue that saturated 
but not unsaturated FAs might trigger such mechanism to 
induce Fyn re-localization. It is known that CD36 and Fyn 
kinase interact [35], thus it is possible that mechanisms 
leading to palmitate-dependent Fyn activation might be 
mediated by CD36, which is induced by palmitate in 
macrophages. Nonetheless, the molecular mechanism of 
activation remains to be investigated and was beyond the 
scope of our study.
We found that, following palmitate exposure, Fyn 
rapidly re-localized into the nucleus of macrophages. 
This was subsequently followed by Nrf2 nuclear 
exclusion. Interestingly, Nrf2 action is also regulated 
by high fat diets; and FA-dependent regulation of 
Nrf2 appears to be dependent on the type of dietary fat 
[38], i.e. saturated fats inhibit Nrf2 signaling whereas 
unsaturated fats activate this pathway [20]. Therefore, it 
appears that FAs regulate Nrf2 function in an opposite 
pattern to that through which they regulate Fyn activity. 
This is consistent with the fact that Fyn exerts an 
inhibitory action on Nrf2. Our data and those of others 
showed that under basal conditions, Nrf2 localized in the 
cytoplasm of cells [28–30]. However, Nrf2 quickly re-
localized to the nucleus after palmitate exposure, along 
with Fyn kinase. This might appear counter-intuitive 
since Fyn inhibits Nrf2 action by promoting Nrf2 nuclear 
exclusion. However, we observed that after this first 
phase, the Nrf2 nuclear signal gradually decreased. As 
Fyn remained in the nucleus, this suggested that Nrf2 
function was inhibited as a consequence of the persistent 
nuclear localization of Fyn. In line with this, we observed 
a decrease in the expression of downstream targets of 
Nrf2 after palmitate exposure. Mechanisms leading to 
Nrf2 initial nuclear localization in response to palmitate 
remain to be elucidated. However, it appears reasonable 
to suggest that this may be a mechanism to protect the 
cells from the deleterious effects of ROS production. 
Supporting this, we observed that expression of the Nrf2 
targets Nqo-1 and HO-1 were transiently elevated shortly 
after palmitate exposure (data not shown). This early 
phase was then inhibited by the persistent presence of 
Fyn in the nucleus, which triggers Nrf2 nuclear exclusion 
and cytosolic degradation.
Importantly, the effects of palmitate on Fyn nuclear 
re-localization were blocked when cells were incubated 
with SU6656 (a Fyn inhibitor), and palmitate-mediated 
inhibition of Nrf2 pathway was lifted. SU6656 is a potent 
Fyn inhibitor but it is also known to inhibit other Src 
kinase family members. Yet, SU6656 reduced palmitate-
induced ROS production in RAW264.7 but had no effect 
in shFyn-RAW264.7 cells (data not shown). This strongly 
supported that SU6656 effects were most likely through 
Fyn specific inhibition. Lastly, SU6656 was recently shown 
to activate AMPK [39] and we have demonstrated that Fyn 
inhibition itself activates AMPK in peripheral tissues [24]. 
Therefore, we cannot exclude that the inhibitory action of 
SU6656 on palmitate downstream effects may be through 
Fyn inhibition combined with AMPK activation. Further 
examinations would be necessary to dissect this possibility 
but, in any case, the ensemble of our data support that Fyn 
kinase activity is necessary for the palmitate-dependent 
inhibition of Nrf2 pathway.
Dietary fats are well-established modulators 
of macrophage function. However, molecular events 
linking FAs to macrophage activation are not completely 
identified. Building on our present data, we provide 
a novel mechanism by which macrophages respond 
differentially to saturated FAs than to unsaturated FAs. 
This occurs through the selective activation of Fyn kinase 
by saturated FAs, and its antagonism by unsaturated 
FAs. This establishes Fyn as an integral component 
of a signaling pathway able to sense dietary cues that 
contribute to the establishment of inflammation in 
nutritional obesity. Further studies are now necessary to 
identify the upstream regulatory mechanisms by which 
saturated and unsaturated FAs differentially regulate Fyn 
kinase activity; and how Fyn is successively transported to 
the nucleus of macrophages.
MATERIALS AND METHODS
Reagents
Rabbit polyclonal Fyn antibody (FYN3), Heme 
Oxygenase-1, Nrf2 (H300), goat polyclonal Nrf2 
(T19) and Nrf2 (C20) antibodies were from Santa Cruz 
Biotechnology (Santa Cruz, CA, USA). GAPDH antibody 
was from MBL international (Woburn, MA, USA). 
LaminA/C and P115 antibodies were from Cell Signaling 
Technology (Danvers, MA, USA).
Animals
Mice homogenous for the Fyntm1Sor targeted 
mutation (129-Fyntm1Sor/J) (fynKO) and their controls 
(129S1/SvImJ) were obtained from the Jackson 
Laboratory (Bar Harbor, ME, USA) and housed in a 
facility equipped with a 12 h light/dark cycle. 8 weeks 
old male mice were fed either a standard chow diet 
(Research Diets, New Brunswick, NJ, USA) containing 
70% (Kcal) carbohydrates, 20 % protein, and 10 % fat or 
a high fat diet containing 20% (Kcal) carbohydrates, 20% 
protein and 60% fat for 8 weeks. Composition of the diets 
D12392 (60% fat) and D12450B (control diet) can be 
found at http://www.researchdiets.com/opensource-diets/
stock-diets. Essentially, saturated fats were increased by 
10% and polyunsaturated fats were reduced by 15% in 
D12492 compared to the control diet. All studies were 
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approved by and performed in compliance with the 
guidelines of the Yeshiva University Institutional Animal 
Care and Use Committee (IACUC).
Bone Marrow Derived Macrophages (BMDM) 
isolation and differentiation
BMDMs from control and fynKO mice were prepared 
using a standard method. Briefly, marrow was flushed 
from the femurs using DMEM media with 10% FBS. The 
suspension was filtered through a 70 μm cell strainer and 
red cells were removed. The remaining precursor cells were 
plated and differentiated into BMDMs with macrophage 
colony-stimulating factor (M-CSF, 10 ng/ml) (R&D 
Systems, Minneapolis, MN, USA). Differentiation was 
typically achieved within 6 days.
Stromal Vascular Fraction (SVF) cells isolation
Minced adipose tissue samples were treated with 
0.05 mg/mL Liberase (TM Research Grade; Roche 
Applied Science, Indianapolis, IN) and incubated at 37°C 
for 20 min. Samples were passed through a sterile 250 mm 
nylon mesh. The suspension was centrifuged at 1,000 xg 
for 5 min. The precipitated cells (SVF) were re-suspended 
in erythrocyte lysis buffer. The erythrocyte-depleted 
SVF cells were centrifuged at 500 xg for 5 min and re-
suspended in DMEM medium supplemented with 10% 
FCS and 1% Penicillin/Streptomycin.
Macrophages isolation
SVF from lean and fat-fed mice (n=5 for the fat-
fed mice and n= 8 for the control mice) were prepared 
as described above. SVF were treated with erythrocyte 
lysis buffer and washed two times in PBS. Positive 
selection to enrich for F4/80 cells was performed using 
the MagniSort Mouse F4/80 positive selection kit 
(eBioscience, Inc,). Briefly, 108 cells were suspended 
in a separation buffer and incubated with the selection 
antibody for 60 min. Cells were washed and selection 
beads were added to the suspension. Following sorting, 
cells were washed and protein homogenates were 
immediately prepared.
Fatty acid preparation and incubation
Palmitic acid (PA) (Sigma, St. Louis, MO, USA) 50 
mM was prepared in methanol and stored at −20°C. On 
the day of use, indicated PA concentrations were prepared 
in fatty acid-free and low endotoxin BSA at a ratio FA: 
BSA= 2. Equal volumes of methanol (final concentration 
< 0.1%) in fatty acid-free BSA were applied to control 
cells. Where Fyn pharmacological inhibitor was used, 
cells were treated with 5 μM SU6656 (Calbiochem, San 
Diego, CA, USA) for 60 min.
Fyn tyrosine activity
Activity was determined with a Universal Tyrosine 
Kinase activity assay kit (Takara Bio Inc., Shiga, Japan). 
Cells were homogenized in a NP40- based buffer. 
Homogenates were centrifuged for 15 min at 14,000 xg 
at 4°C and supernatants were collected. Whole cell lysates 
(0.5-1 mg) were incubated with 4 μg of FYN3 rabbit 
polyclonal antibody coupled with Catch and Release 
columns (Millipore, Billerica, MA, USA) for 2 h at 
4°C. Immuno-complexes were diluted and samples were 
mixed with an ATP solution before being incubated in an 
ELISA plate. Kinase activity was corrected by the protein 
concentration.
Quantitative PCR analysis
Cells were homogenized into QIAzol Lysis 
Reagent. Total RNA was isolated using RNeasy® Mini 
Kit (Qiagen Sciences, Maryland, USA) and reverse-
transcribed to cDNA using the SuperScript VILO cDNA 
synthesis kit (Invitrogen, Carlsbad, CA, USA). TaqMan 
(Applied Biosystems, Branchburg, NJ, USA) RT-PCR was 
performed for measurement of mRNA of Tumor Necrosis 
Factor-alpha (TNF-a) (Mm00443260_g1), Interleukin-6 
(IL-6) (Mm00446190_m1), Nitric oxide synthase-2 (Nos2) 
(Mm00440502_m1), Fyn (Mm00433373_m1), Heme 
Oxygenase-1 (HO-1) (Mm00516005_m1), NAD(P)H 
dehydrogenase [quinone]-1 (Nqo-1) (Mm01253561_m1), 
and NAD(P)H Oxidase. Relative expression levels of the 
mRNAs were determined using standard curves using the 
Applied Biosystems 7900HT Sequence Detection System 
from Applied Biosystems. Samples were adjusted for total 
mRNA content by comparison with Rpl7 expression. All 
primer-probe mixtures were from Applied Biosystems 
(Branchburg, NJ, USA).
Western blotting
Cells were homogenized in a NP-40 lysis buffer 
containing protease and phosphatase inhibitors and 
protein concentration was determined using the BCA 
method. Homogenates were centrifuged for 15 min 
at 13,000 xg at 4°C and supernatants were collected. 
Protein samples (40 μg) were separated onto 8 or 10% 
reducing polyacrylamide gels and electroblotted onto 
Immobilon-P polyvinylidene difluoride membranes (Bio-
Rad Laboratories, Hercules, CA, USA). Immunoblots 
were blocked either 5% milk in Tris-buffered saline or 
with Blocking Buffer for Fluorescent Western Blotting 
(Rockland Antibodies & Assays, Gilbertsville, PA, USA) 
for 2 h at room temperature and incubated overnight at 
4°C with the indicated antibodies in Tris-buffered saline 
and 0.05% Tween 20 (TBST) containing 1% BSA. 
Membranes were washed in TBST and incubated with 
horseradish peroxidase-conjugated secondary antibodies 
(1:30,000) for 45 min at room temperature. Membranes 
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were washed in TBST, and antigen-antibody complexes 
were visualized by chemiluminescence using an ECL kit 
(Pierce, Rockford, IL, USA). Alternatively, immunoblots 
were incubated with IRDye800CW Goat Anti Mouse 
(H+L) or IRDye680 Goat Anti Rabbit (H+L) secondary 
antibodies and signal was detected with the Odyssey® 
Infrared Imaging System (Li-COR Biotechnology, 
Lincoln, NE, USA). The relative band intensity was 
quantified using the ImageJ software.
Nuclear and cytoplasmic protein fractions
Cells were treated as indicated and nuclear and 
cytoplasm extracts were prepared using a kit from Pierce 
(Rockford, IL, USA). Proteins were separated onto 10% 
reducing polyacrylamide gels and electroblotted onto 
Immobilon-P polyvinylidene difluoride membranes. 
Immunoblots were processed as described above. 
Antigen-antibody complexes were visualized by 
chemiluminescence or using the Odyssey® Infrared 
Imaging System, as above.
Cell culture and silencing
The human embryonic kidney cells (HEK-293T), 
the mouse macrophage cell lines RAW264.7 (ATCC 
TIB-71) and J774 (ATCC TIB-67) were obtained from 
ATCC (Manassas, VA, USA) and maintained in DMEM 
supplemented with 10% fetal calf serum and 1% 
penicillin/streptomycin at 37°C in a humidified incubator 
with 5% CO2. Fyn kinase-silenced and control stable cell 
lines were produced by transducing the macrophage cell 
lines with either MISSION shRNA lentivirus Fyn particles 
(TRCN000023380) or MISSION non-mammalian 
target shRNA control particles (SHC002) (Sigma). The 
transduced cells were selected with 3 μg/ml Puromycin 
for 10 days.
Transient transfections of HEK293 cells were 
performed using the FugeneHD (Roche Applied Science, 
Basel, Switzerland) according to the manufacturer’s 
protocol.
Immunofluorescence
Cells were seeded in 8 wells-chamber slides 
and stimulated with PA, oleate, DHA or SU6656. 
After the indicated incubation time, cells were washed 
with PBS and fixed for 30 min in PBS containing 4% 
paraformaldehyde and 2% sucrose, followed by three 
washes in PBS. Slides were incubated in PBS with 
Triton-X-100 (PBST) for 5 min at 4°C to permeabilize 
the cells. Cells were washed and blocked in PBST with 
BSA 5% for 1 h at room temperature and incubated with 
either Fyn or Nrf2 antibody diluted 1:200 in PBST-BSA 
2%, followed by Alexa Fluor 488 anti-rabbit IgG or 
IgG or Alexa Fluor 594 anti-goat IgG for 1 h at room 
temperature. Samples were mounted with Prolong 
Gold anti-fade reagent with DAPI (Life Technologies). 
Fluorescence images were acquired using a confocal 
fluorescence microscope (TCS SP5 confocal; Leica 
microsystems, Buffalo Grove, IL, USA).
Cellular reactive oxygen species detection assay
Cells were seeded onto 96 wells plate and pre-
loaded with 10 μM 2′,7′-dichlorodihydrofluorescein 
diacetate (H2DCFDA) (Life Technologies) at 37°C for 
60 min at room temperature. Cells were PBS rinsed (2 
times) and reactive oxygen species (ROS) production was 
assessed by quantifying the fluorescence of the cells after 
PA exposure (10 min) using the BioTek Synergy 2 plate 
reader (BioTek Instruments, Winooski, VT, USA).
Statistics
Results are expressed as mean ± standard error of 
the mean (s.e.m). The data were analyzed by one-way 
ANOVA followed by post hoc analysis for comparisons 
between individual groups when group numbers were >2. 
Differences were considered statistically significant at a 
level of p<0.05. Differences between 2 treatments were 
tested for statistical significance (p<0.05) using a Student’s 
unpaired t-test.
Abbreviations
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